Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016)

Insight Molecular Diagnostics (IMDX) posted Current Taxes of $151000.0 for Q4 2016, little changed sequentially from $151000.0 in Q3 2016, and up 277.5% YoY from $40000.0 in Q1 2016.

Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016) Analysis & Trends

Insight Molecular Diagnostics (IMDX) has 2 years of Current Taxes data on file, last reported at $151000.0 in Q4 2016.

  • Quarterly Current Taxes rose 277.5% year-over-year to $151000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $151000.0 (up 277.5% YoY) and the FY2016 annual result came in at $151000.0, up 277.5% from the prior year.
  • Current Taxes steadied at $151000.0 in Q4 2016 per IMDX's latest filing, from $151000.0 in the prior quarter.
  • The five-year high for Current Taxes was $151000.0 in Q2 2016, with the low at $40000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 47.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn -
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 172.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 161.48 Mn
10 Insight Molecular Diagnostics 196.41 Mn 167.48 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2016 151,000.00
Sep 30, 2016 151,000.00
Jun 30, 2016 151,000.00
Dec 31, 2015 40,000.00